Oxigene, Inc.

Oxigene, Inc.

Sector: Biological Products Except Diagnostic Substances Region: CA, United States

: | Nasdaq: OXGN

Similar to: ALLENEX AB, NPS Pharmaceuticals, Inc., Bebra Biogas Holding AG

Oxigene, Inc. engages in the development of therapeutics to treat cancer and eye diseases. It offers anti-vascular drugs referred to as vascular disrupting agents. Its products include Zybrestat (fosbretabulin) and Zybrestat Topical. The company was founded in 1988 and is headquartered in South San Francisco, CA.

News & Analysis

You may also be interested in: